Postextrasystolic blood pressure potentiation predicts poor outcome of cardiac patients

Journal of the American Heart Association

Volumn 3, Issue 3, 2014, Pages

  Sinnecker, Daniel ^a   Dirschinger, Ralf J ^a   Barthel, Petra ^a   Müller, Alexander ^a   Morley Davies, Adrian ^b   Hapfelmeier, Alexander ^c   Dommasch, Michael ^a   Huster, Katharina M ^a   Hasenfuss, Gerd ^d   Laugwitz, Karl Ludwig ^a,f   Malik, Marek ^e   Schmidt, Georg ^a,f  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY HOSPITAL OF NORTH STAFFORDSHIRE   (United Kingdom)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d UNIVERSITY OF GÖTTINGEN   (Germany)

^e IMPERIAL COLLEGE LONDON   (United Kingdom)

^f DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

Author keywords

calcium cycling; Myocardial infarction; Risk assessment

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CLOPIDOGREL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ACUTE HEART INFARCTION; ADULT; ARTICLE; BLOOD CLOT LYSIS; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; CALCIUM SIGNALING; CARDIAC PATIENT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CLINICAL TRIAL; CONTROLLED STUDY; DEATH; DIABETES MELLITUS; ELECTROCARDIOGRAM; FEMALE; HEART BEAT; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CONTRACTILITY; HEART VENTRICLE EXTRASYSTOLE; HOSPITAL DISCHARGE; HUMAN; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; POST EXTRA SYSTOLIC POTENTIATION; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROBABILITY; PROSPECTIVE STUDY; PULSE WAVE; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SCORING SYSTEM; SECONDARY PREVENTION; SINUS RHYTHM; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SUDDEN CARDIAC DEATH; SYSTOLIC BLOOD PRESSURE; AGED; ELECTROCARDIOGRAPHY; EXTRASYSTOLE; HEART INFARCTION; HEART STROKE VOLUME; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; RISK FACTOR;

AGED; BLOOD PRESSURE; CARDIAC COMPLEXES, PREMATURE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROSPECTIVE STUDIES; RISK FACTORS; STROKE VOLUME; VENTRICULAR PREMATURE COMPLEXES;

EID: 84908304506     PISSN: None     EISSN: 20479980     Source Type: Journal    
DOI: 10.1161/JAHA.114.000857     Document Type: Article

References (32)

1. Langendorff O. Ueber elektrische Reizung des Herzens. Du-Bois-Reymond's Archiv f. Physiologie. 1885;8:284-287.
2. Langendorff O. Untersuchungen am überlebenden Säugetierherzen III. Abhandlung: Unregelmäßigkeiten des Herzschlages und ihre Ausgleichung. Pflügers Archiv für die gesamte Physiologie. 1898;70:473-486.
3. Bornstein A. Die Postextrasystole. Zbl Physiol. 1906;20:401-405.
4. Hoffman BF, Bindler E, Suckling EE. Postextrasystolic potentiation of contraction in cardiac muscle. Am J Physiol. 1956;185:95-102.
5. Wiggers CJ. The Henry Jackson memorial lecture: dynamics of ventricular contraction under abnormal conditions. Circulation. 1952;5:321-348.
6. Beck W, Chesler E, Schrire V. Postextrasystolic ventricular pressure responses. Circulation. 1971;44:523-533.
7. Merillon JP, Motte G, Aumont MC, Masquet C, Lecarpentier Y, Gourgon R. Postextrasystolic left ventricular peak pressure with and without left ventricular failure. Cardiovasc Res. 1979;13:338-344.
8. Seed WA, Noble MI, Walker JM, Miller GA, Pidgeon J, Redwood D, Wanless R, Franz MR, Schoettler M, Schaefer J. Relationships between beat-to-beat interval and the strength of contraction in the healthy and diseased human heart. Circulation. 1984;70:799-805.
9. Cooper MW. Postextrasystolic potentiation. Do we really know what it means and how to use it? Circulation. 1993;88:2962-2971.
10. Hoit BD, Tramuta DA, Kadambi VJ, Dash R, Ball N, Kranias EG, Walsh RA. Influence of transgenic overexpression of phospholamban on postextrasystolic potentiation. J Mol Cell Cardiol. 1999;31:2007-2015.
11. Zaugg CE, Kojima S, Wu ST, Wikman-Coffelt J, Parmley WW, Buser PT. Intracellular calcium transients underlying interval-force relationship in whole rat hearts: effects of calcium antagonists. Cardiovasc Res. 1995;30:212-221.
12. Hasenfuss G, Pieske B. Calcium cycling in congestive heart failure. J Mol Cell Cardiol. 2002;34:951-969.
13. Iribe G, Kohl P, Noble D. Modulatory effects of calmodulin-dependent kinase II (CaMKII) on sarcoplasmic reticulum Ca2+ handling and interval-force relations: a modelling study. Philos Trans A Math Phys Eng Sci. 2006;364:107-133.
14. Barthel P, Bauer A, Müller A, Huster KM, Kanters JK, Paruchuri V, Yang X, Ulm K, Malik M, Schmidt G. Spontaneous baroreflex sensitivity: prospective validation trial of a novel technique in survivors of acute myocardial infarction. Heart Rhythm. 2012;8:1288-1294.
15. Bauer A, Morley-Davies A, Barthel P, Müller A, Ulm K, Malik M, Schmidt G. Bivariate phase-rectified signal averaging for assessment of spontaneous baroreflex sensitivity: pilot study of the technology. J Electrocardiol. 2010; 43:649-653.
16. Eagle KA, Lim MJ, Dabbous OH, Pieper KS, Goldberg RJ, Van de Werf F, Goodman SG, Granger CB, Steg PG, Gore JM, Budaj A, Avezum A, Flather MD, Fox KA; GRACE Investigators. A validated prediction model for all forms of acute coronary syndrome: estimating the risk of 6-month postdischarge death in an international registry. J Am Med Assoc. 2004;291:2727-2733.
17. Barthel P, Wensel R, Bauer A, Müller A, Wolf P, Ulm K, Huster KM, Francis DP, Malik M. Respiratory rate predicts outcome after acute myocardial infarction: a prospective cohort study. Eur Heart J. 2013;34:1644-1650.
18. The Multicenter Postinfarction Research Group. Risk stratification and survival after myocardial infarction. N Engl J Med. 1983;309:331-336.
19. Boulesteix AL, Hothorn T. Testing the additional predictive value of highdimensional data. BMC Bioinformatics. 2010;10:78.
20. Uno H, Tian L, Cai T, Kohane IS, Wei LJ. A unified inference procedure for a class of measures to assess improvement in risk prediction systems with survival data. Stat Med. 2013;32:2430-2442.
21. Uno H, Cai T. survIDINRI: IDI and NRI for comparing competing risk prediction models with censored survival data. 2013. R package version 1.1-1. Availalbe at: http://CRAN.R-project.org/package=survIDINRI. Accessed April 2, 2014.
22. Youden WJ. Index for rating diagnostic tests. Cancer. 1950;3:32-35.
23. Böhning D, Böhning W, Holling H. Revisiting Youden's index as a useful measure of the misclassification error in meta-analysis of diagnostic studies. Stat Methods Med Res. 2008;17:543-554.
24. DiCiccio TJ, Efron B. Bootstrap confidence intervals. Stat Sci. 1996;11:189-228.
25. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristics curves: a nonparametric approach. Biometrics. 1988;44:837-845.
26. Schmidt G, Malik M, Barthel P, Schneider R, Ulm K, Rolnitzky L, Camm AJ, Bigger JT Jr, Schömig A. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet. 1999;353:1390-1396.
27. Bauer A, Malik M, Schmidt G, Barthel P, Bonnemeier H, Cygankiewicz I, Guzik P, Lombardi F, Müller A, Oto A, Schneider R, Watanabe M, Wichterle D, Zareba W. Heart rate turbulence: standards of measurement, physiological interpretation, and clinical use: International Society for Holter and Noninvasive Electrophysiology consensus. J Am Coll Cardiol. 2008;52: 1353-1365.
28. Kadambi VJ, Ponniah S, Harrer JM, Hoit BD, Dorn GW, Walsh RA, Kranias EG. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocytes mechanics in transgenic mice. J Clin Invest. 1996;97:533-539.
29. Schillinger W, Fiolet JW, Schlotthauer K, Hasenfuss G. Relevance of Na+-Ca2+ exchange in heart failure. Cardiovasc Res. 2003;57:921-933.
30. Pogwizd SM, Bers DM. Calcium cycling in heart failure: the arrhythmia connection. J Cardiovasc Electrophysiol. 2002;13:88-91.
31. Jacobshagen C, Belardinelli L, Hasenfuss G, Maier LS. Ranolazine for the treatment of heart failure with preserved ejection fraction: background, aims, and design of the RALI-DHF study. Clin Cardiol. 2011;34:426-432.
32. Marks AR. Caclium cycling proteins and heart failure: mechanisms and therapeutics. J Clin Invest. 2013;123:46-52.